Index Ventures is set to announce a new, $578 million European venture fund that will back a fresh slate of bets in the biotech field. And it's hired some top hands to run the fund: Dominique Vidal, the former CEO of Yahoo Europe, and Guido Magni, former global head of medical science at Roche. They plan to make about 15 investments averaging €25 million each, targeting companies with a revenue growth rate of 25 percent or more.
"We can provide pre-initial public offering financing, or funding for acquisitions to help companies achieve further growth," said Vidal, striking a tone that seemed to be geared more to technology than biotechnology.
- see this release
- read the report from the Financial Times